retatrutide patent eli lilly Retatrutide: Lilly's Bold Gamble for Biologic Status – What It Means for the Future of Obesity Treatment Eli Lilly's Retatrutide Clears Two

But retatrutide is the molecule that made people ask whether even tirzepatide might get outclassed

Medical weight loss can reduce risks of obesity-related conditions like high blood pressure, diabetes, heart disease, and digestive or kidney diseases

GLP-1 promotes the release of insulin to regulate blood sugar (glucose) levels and appetite

Orforglipron: Phase 3 trial results are expected in 2025

Due to its insulinotropic action (stimulates insulin secretion), GLP-1-based treatments effectively prevent postprandial hyperglycemia (post-meal glucose spikes) in patients with T2DM

How should Retatrutide (15 mg) be stored and handled